- Specialist amino acid solution for use in parenteral nutrition for neonates, infants and children
- A mixture of essential and non-essential amino acids
- Extensive compatibility and stability data with parenteral nutrition regimens are available upon request from our medical information team: Medical.Information-UK@fresenius-kabi.com
Vaminolact®
(amino acids)
- Filename
- Macronutrient Prescribing Information.pdf
- Size
- 209 KB
- Format
Details
- Benefits
- Composition
- Features
- Indication
- Presentation and order codes
| Contents per 1000ml | |
|---|---|
| Nitrogen | 9.3g |
| Amino Acids | 65.3g |
| Energy | 240kcal |
- Supplies taurine, cysteine, tyrosine, methionine and phenylalanine; essential and semi-essential amino acids in the neonatal and newborn period
- When used in neonates and children below 2 years, the solution (in bags and administration sets) should be protected from light exposure until administration is completed
- To achieve optimal utilisation of administered amino acids, adequate energy sources should be provided together with electrolytes, trace elements and vitamins
- Electrolyte free
Clinical conditions in children when enteral supply of protein is insufficient, undesirable or impossible.
| Item description | Item code | Unit size | Case qty |
| Vaminolact® | 1383031 | 100ml | 10 |
| 1383091 | 500ml | 10 |
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk Adverse events should also be reported to Fresenius Kabi Limited. Email: Pharmacovigilance.GB@fresenius-kabi.com
GB-Vamct-2400003 January 2025